Nonsquamous Non-small Cell Lung Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-11-08
Clinical Trial Update: A Study of Sintilimab or Placebo in Combination With Chemotherapy as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer With Wild-type EGFR After Failure With Platinum-Containing Chemotherapy. [Phase 2]
A Phase 2 clinical trial evaluating sintilimab or placebo plus chemotherapy as second-line treatment for stage IV nonsquamous non-small cell…